Increased Circulatory Extrarenal 1?,25-Dihydroxyvitamin D3 in Bilaterally Nephrectomized Rats
| dc.contributor.author | Dabak, Murat | |
| dc.contributor.author | Dabak, Durrin O. | |
| dc.contributor.author | Kuloglu, Tuncay | |
| dc.contributor.author | Baydar, Ersoy | |
| dc.contributor.author | Bulut, Hakan | |
| dc.contributor.author | Ozoner, Ozgur | |
| dc.date.accessioned | 2026-08-12T17:18:38Z | |
| dc.date.issued | 2020 | |
| dc.department | Fırat Üniversitesi | |
| dc.description.abstract | Background: Extrarenal 1 alpha,25-dihydroxyvitamin D-3 (1,25-D) locally produced by immune cells plays crucial roles in the regulation of the immune system. However, in vivo status of extrarenal 1,25-D and 25-hydroxyvitamin D (25-D) in acute inflammatory conditions are unknown. Objective: The aim of this study was to determine the extrarenal 1,25-D level in circulation in bilaterally nephrectomized rats, induced by low-dose lipopolysaccharide (LPS). Methods: Renal 1,25-D synthesis was terminated through bilateral nephrectomy in rats. The rats received intraperitoneal LPS (50 mu g/kg BW) three times and the experiment was ended 24 hours after nephrectomy. Serum 1,25-D, 25-D, calcium, phosphorus, intact parathyroid hormone, and calcitonin levels were measured and immunohistochemistry was applied to detect the sources of extrarenal 1,25-D synthesis. Results: Circulatory 1,25-D concentration remarkably increased in both LPS-treated and non-treated bilaterally nephrectomized rats. Elevated circulatory 1,25-D did not have hypercalcemic endocrinal effects. The increased 1,25-D level also resulted in a concurrent rapid and dramatic depletion of circulatory 25-D. Conclusion: Extrarenal 1,25-D could enter into the systemic circulation and, therefore, might have systemic effects besides its autocrine and paracrine functions. | |
| dc.description.sponsorship | Scientific and Technological Research Council of Turkey (TUBITAK) [2140681] | |
| dc.description.sponsorship | This work was supported by the Scientific and Technological Research Council of Turkey (TUBITAK) (Project Number: 2140681). | |
| dc.identifier.doi | 10.2174/1871530320666200530222426 | |
| dc.identifier.endpage | 1530 | |
| dc.identifier.issn | 1871-5303 | |
| dc.identifier.issn | 2212-3873 | |
| dc.identifier.issue | 9 | |
| dc.identifier.orcid | 0000-0001-9874-3838 | |
| dc.identifier.orcid | 0000-0001-7354-0655 | |
| dc.identifier.orcid | 0000-0002-5184-6087 | |
| dc.identifier.pmid | 32473004 | |
| dc.identifier.scopus | 2-s2.0-85092184002 | |
| dc.identifier.scopusquality | Q2 | |
| dc.identifier.startpage | 1523 | |
| dc.identifier.uri | https://doi.org/10.2174/1871530320666200530222426 | |
| dc.identifier.uri | https://hdl.handle.net/11508/53120 | |
| dc.identifier.volume | 20 | |
| dc.identifier.wos | WOS:000587329600017 | |
| dc.identifier.wosquality | Q3 | |
| dc.indekslendigikaynak | Web of Science | |
| dc.indekslendigikaynak | Scopus | |
| dc.indekslendigikaynak | PubMed | |
| dc.language.iso | en | |
| dc.publisher | Bentham Science Publ Ltd | |
| dc.relation.ispartof | Endocrine Metabolic & Immune Disorders-Drug Targets | |
| dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.snmz | KA_WoS_20260511 | |
| dc.subject | 1 alpha,25-dihydroxyvitamin D-3 | |
| dc.subject | 25-hydroxyvitamin D | |
| dc.subject | inflammation | |
| dc.subject | extrarenal | |
| dc.subject | anephric | |
| dc.subject | rat | |
| dc.title | Increased Circulatory Extrarenal 1?,25-Dihydroxyvitamin D3 in Bilaterally Nephrectomized Rats | |
| dc.type | Article |







